Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small cell lung cancer

Journal Title: Indian Journal of Pharmaceutical and Biological Research - Year 2015, Vol 3, Issue 2

Abstract

Aberrant increased expression and activation of receptor tyrosine kinases occur frequently in human carcinomas. Several small molecules targeting receptor tyrosine kinases, which have crucial roles in the growth factor signaling that promote tumor progression in various malignancies, including non-small cell lung cancer (NSCLC), are currently in clinical development. Therapeutic strategies include inhibition of growth factor tyrosine kinase function. Drugs of this type include those that target the epidermal growth factor receptor tyrosine kinase, those that target vascular endothelial growth factor receptors tyrosine kinase and those that target anaplastic lymphoma receptor tyrosine kinase. In this review we first discuss the role of receptor tyrosine kinases in human malignancies, and focus on discussing the potential use of epidermal growth factor receptor tyrosine kinase inhibitors and the vascular endothelial growth factor receptors tyrosine kinase inhibitors in NSCLC. In addition, we discuss the contribution of growth factor receptor tyrosine kinase inhibitors to the clinically observed resistance, and toxicity.

Authors and Affiliations

Lawaly Maman Manzo| Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, P. R., China Laboratoire de Biochimie Clinique, Hopital National de Niamey, BP 238 Niamey, Niger, Moudirat Lawaly| Centre National de Traitement du Cancer, BP 238 Niamey, Niger, Lui YU| Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, P. R., China

Keywords

Related Articles

Idiopathic granulomatous mastitis: a great diagnostic challenge

Idiopathic granulomatous mastitis is a rare chronic inflammatory lesion of breast which presents as a spectrum of diseases and is diagnosed only histological. It is often a diagnosis of exclusion in most of the cases....

Hepatoprotective potential of Trigonella foenum graecum in deltamethrin induced albino rats

Objective: Aim of investigation focuses attention on hepatoprotective and antioxidative effect of aqueous extract of Trigonella foenum graecum (TFG) in hepatic tissue of deltamethrin fed rats. Methods: In a 45 days tre...

A study of clinical, metabolic and hematological profile in infants of diabetic mothers

Background:Diabetes has long been associated with maternal and perinatal mobidity and mortality. Infants of diabetic mothers (IDMs) have higher risks for serious problems during pregnancy, delivery and early neonatal p...

Ingredients identification and quality control evaluation of phalakalyan ghrita: an ayurvedic formulation

Infertility is defined as failure to conceive within one year or more than one year of regular & unprotected coitus. It is the most sensitive and cumbersome problem which haunts every couple. Total 10-15% of world popu...

Development of quality control parameters for the standardization of Leaves and bark of Sida acuta Burm.f

Sidha acuta Burm. f belonging to family Malvaceae is a terrestrial, erect shrub which is up to 155 cm tall. The plant is native to Mexico, Central America and Himalayan region of India but has spread throughout the tro...

Download PDF file
  • EP ID EP15338
  • DOI -
  • Views 351
  • Downloads 13

How To Cite

Lawaly Maman Manzo, Moudirat Lawaly, Lui YU (2015). Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small cell lung cancer. Indian Journal of Pharmaceutical and Biological Research, 3(2), 81-87. https://europub.co.uk/articles/-A-15338